NAD



NAD


SMILES NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1
InChIKey BAWFJGJZGIEFAR-NNYOXOHSSA-N

Chemical Properties

Hydrogen bond acceptors 18
Hydrogen bond donors 7
Rotatable bonds 11
Molecular weight (Da) 663.1


No bioactivity data available.

NAD


Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I
Phase II
Phase III
Phase IV


Compound is not listed as a drug.